Brief: Lumibird Medical Obtains CE Marking For C.Diag, A Platform To Help Diagnose Dry Eye
May 3 (Reuters) - Lumibird SA LBIRD.PA :
* LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A
PLATFORM TO
HELP DIAGNOSE DRY EYE
* THIS EUROPE-WIDE LAUNCH FOLLOWS CE MARKING CERTIFIED BY
LNE-GMED
ON 30 APRIL 2024
* MARKET ESTIMATED TO BE WORTH $6.4 BILLION IN 2024
Source text for Eikon: ID:nGNEbQMbF8
Further company coverage: LBIRD.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Lumibird SA
See all newsBrief: Lumibird - H1 Net Income Up +4.5% To EUR 5.1 Million
Brief: Lumibird Signs A Share Purchase Agreement For The Sale Of Lumibird Medical To IPG Photonics Corporation
Brief: Lumibird H1 Revenue Up +9.7% Lfl to €114.7 Mln
Brief: Lumibird Signs Agreement With Cilas
Brief: Lumibird Enters Into Exclusive Negotiations For The Sale Of Its Medical Division To IPG Photonics Corporation